Addison’s Disease Treatment Market Highlights
Addison's Syndrome Over the forecast period, the
market is predicted to increase considerably. The market is expected to be
worth USD 587.45 million in 2030, and it is expected to increase at a CAGR of 10.70%
over the forecast period.
Addison’s disease occurs when the body starts
producing inadequate amounts of certain hormones produced by adrenal glands.
The glands start to produce too less cortisol and aldosterone as well. Addison’s disease is a rare disorder, and only 1 in 100,000 people suffer from it.
The increasing prevalence of Addison’s disease and rising research & development activities
to produce new products for diagnosing and treating diseases is expected to
drive market growth over the forecast period. According to a report published
by the National Centre for Biotechnology Information in June 2017, the
incidence rate of Addison’s disease is 0.6 per 100,000 of the population per
year. Despite the drivers, difficulty in diagnosis in early stages and lack of
knowledge can restrain the market growth over the assessment period.
The Addison's
Disease Market Size is undergoing significant evolution, with promising
developments for patients worldwide. Addison's Disease, a rare endocrine
disorder characterized by insufficient adrenal gland hormone production, has
seen a surge in research and treatment options. Pharmaceutical companies are
investing in innovative therapies, targeting hormone replacement and
immunomodulation to improve patients' quality of life.
Advanced diagnostic tools are also emerging,
enabling earlier disease detection and personalized treatment plans.
Telemedicine platforms and patient support organizations play pivotal roles in
raising awareness and providing education and support. While Addison's Disease
remains a niche market, the growing commitment to research and patient care
bodes well for those living with this challenging condition, offering hope for
a brighter future.
Addison’s
Disease Treatment Market Players
The global Addison’s Disease Market
research players
are Pfizer Inc., Boehringer Ingelheim International GmbH, Shire, Tocris
Bioscience, GlaxoSmithKline plc, Merck KGaA, Lupin Pharmaceuticals, Inc.,
Abbott, Amgen Limited & Amgen Ireland Limited, Bayer AG, Biogen, Eli Lilly
and Company, Novartis AG, Diurnal, Switzer Life science Pvt. Ltd., and others.
Segmentation
The global Addison’s Disease Market has been
segmented into diagnosis, treatment, and end user.
The market, based on diagnosis, has been segmented
into clinical laboratory test and imaging tests. Laboratory testing is further segmented into blood
tests, ACTH stimulation test, insulin-induced hypoglycaemia test, and other
tests. Imaging tests are further segmented into chest radiography and CT scan.
The global market, on the basis of treatment, has
been segmented into oral corticosteroids and corticosteroid injections. Oral
corticosteroids are expected to hold the largest share owing to high
preferability of oral dosage forms like tablets. Corticosteroid injections are
anticipated to be the fastest growing segment owing to the less time required
for diffusing in the bloodstream through this mode.
The global Addison’s disease market, by end user,
has been segmented into hospitals and clinics, diagnostic laboratories, and
other end users.
Regional Analysis
Geographically, the Americas is expected to
dominate the global market owing to the presence of well-developed healthcare
sector, raising awareness of the disease and favourable reimbursement policies.
Europe is expected to hold the second largest position in the global market
owing to the growing awareness about the disease coupled with increasing
healthcare expenditure. Asia-Pacific is expected to be the fastest growing
market owing to the rising prevalence of the rare disease marketing and increasing developments in pharmaceuticals
& diagnostics segment. Furthermore, the Middle East and Africa region are
expected to account for the least Addison’s
disease market share in
the global market.
About
US:
Market Research Future (MRFR), enable customers to
unravel the complexity of various industries through Cooked Research Report
(CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R),
Continuous-Feed Research (CFR), and Market Research & Consulting Services.
Contact us:
Market Research Future (part of Wantstats Research
and Media Private Limited),
99 Hudson Street,5Th Floor, New York,
New York 10013
United States of America
